Title	Publication Date	Language	Citations
European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination	2015/12/01	English	169
Validation of the vaccine conspiracy beliefs scale	2016/12/01	English	151
Therapeutic vaccines for high-risk HPV-associated diseases	2018/06/01	English	131
No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study	2018/06/01	English	121
Towards the global elimination of cervical cancer	2019/12/01	English	112
The feminization of HPV: How science, politics, economics and gender norms shaped U.S. HPV vaccine implementation	2017/06/01	English	96
Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis	2019/12/01	English	75
Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years	2017/12/01	English	72
Refining our understanding of cervical neoplasia and its cellular origins	2019/06/01	English	65
Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines	2015/12/01	English	64
Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection	2015/12/01	English	61
Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action	2018/06/01	English	57
Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia	2015/12/01	English	53
Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study	2016/12/01	English	51
Need for expanded HPV genotyping for cervical screening	2016/12/01	English	51
Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women	2019/06/01	English	50
Knowledge, attitudes, and perception towards human papillomavirus among university students in Pakistan	2016/12/01	English	46
HPV vaccination of immunocompromised hosts	2017/12/01	English	46
Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016	2017/12/01	English	46
Seroconversion following anal and genital HPV infection in men: The HIM study	2015/12/01	English	45
HPV and skin carcinogenesis	2019/06/01	English	44
Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases	2018/06/01	English	41
Modulation of antigen presenting cell functions during chronic HPV infection	2017/12/01	English	41
When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysis	2015/12/01	English	40
HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control	2019/12/01	English	37
Overcoming barriers in HPV vaccination and screening programs	2017/12/01	English	36
HPV vaccination in HIV infection	2019/12/01	English	36
Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data	2016/12/01	English	36
Knowledge about HPV and vaccination among young adult men and women: Results of a national survey	2019/06/01	English	36
The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection	2019/06/01	English	35